ストックスクリーナーアプリを入手
0.9675
4.04%
0.0376
前日終値:
$0.9299
開ける：
$0.9277
24時間の取引高:
2.67M
Relative Volume:
1.25
時価総額：
$377.39M
収益：
$105.90M
当期純損益:
$-61.49M
株価収益率:
-4.9062
EPS:
-0.1972
ネットキャッシュフロー:
$-82.65M
1週間 パフォーマンス:
+9.63%
1か月 パフォーマンス:
-1.74%
6か月 パフォーマンス:
-24.41%
1年 パフォーマンス:
-16.59%
1日の値動き範囲:
$0.91
$0.9723
1週間の範囲:
$0.8701
$0.99
52週間の値動き範囲:
$0.8701
$1.72
Standard Biotools Inc Stock (LAB) Company Profile
Compare LAB vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
0.9675 | 362.73M | 105.90M | -61.49M | -82.65M | -0.1972 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-13 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-02-27 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | 開始されました | TD Cowen | Buy |
| 2024-04-04 | 開始されました | Jefferies | Buy |
| 2023-07-12 | 開始されました | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc (LAB) 最新ニュース
Standard BioTools Inc. (NASDAQ:LAB) Sees Large Growth in Short Interest - MarketBeat
Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is Why - Insider Monkey
Fundamentals Check: Is Standard BioTools Inc a strong growth stock2026 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn
Will Standard BioTools Inc stock hit new highs in YEARWeekly Trading Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Meme Stocks: Is Standard BioTools Inc impacted by rising ratesQuarterly Earnings Report & Weekly Return Optimization Alerts - baoquankhu1.vn
Published on: 2026-04-09 16:18:59 - baoquankhu1.vn
Quarterly Earnings: Is Standard BioTools Inc impacted by rising ratesTrade Entry Report & Smart Swing Trading Techniques - baoquankhu1.vn
Standard BioTools (NASDAQ: LAB) CFO equity awards and tax share withholding - Stock Titan
Aug Ideas: Should I invest in Standard BioTools Inc before earnings2026 Year in Review & High Accuracy Investment Signals - baoquankhu1.vn
Technical Analysis: Can Standard BioTools Inc stock double in the next yearQuarterly Performance Summary & Momentum Based Trading Signals - baoquankhu1.vn
Aug Setups: How does Standard BioTools Inc correlate with Nasdaq2026 Macro Impact & Community Consensus Stock Picks - baoquankhu1.vn
Standard BioTools (LAB) Price Target Decreased by 12.68% to 1.58 - MSN
LAB SEC FilingsSTANDARD BIOTOOLS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Can Standard BioTools Inc scale operations efficiently2026 Big Picture & Detailed Earnings Play Strategies - baoquankhu1.vn
Growth Value: Is Standard BioTools Inc impacted by rising rates2026 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
Standard BioTools Inc (LAB) Stock Price Quote Today & Current Price Chart - Capital.com
Short Interest in Standard BioTools Inc. (NASDAQ:LAB) Declines By 18.5% - MarketBeat
Can Standard BioTools Inc stock double in the next yearCEO Change & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Tranche Update on Standard BioTools Inc.'s Equity Buyback Plan announced on March 1, 2024. - marketscreener.com
Downgrade Watch: Will Standard BioTools Inc stock hit new highs in YEAR2026 Fed Impact & High Return Trade Opportunity Guides - baoquankhu1.vn
Analysis Recap: Is Standard BioTools Inc impacted by rising rates2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Earnings Risk: Is Standard BioTools Inc impacted by rising rates2026 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Pullback Watch: Does Standard BioTools Inc have declining or rising EPSMarket Sentiment Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Whale Trades: Can Standard BioTools Inc stock double in the next yearGDP Growth & Safe Entry Momentum Tips - baoquankhu1.vn
Long Focus Capital Management LLC Acquires 1,292,804 Shares of Standard BioTools Inc. $LAB - MarketBeat
Standard BioTools Inc. $LAB Shares Purchased by Mak Capital One LLC - MarketBeat
Standard BioTools Inc. 2025 Annual Report: Market Overview, Innovation, and Regulatory Landscape in Life Sciences Tools - Minichart
Standard BioTools 2025 10-K: Revenue $85.3M, EPS $(0.20) - TradingView
Standard BioTools (NASDAQ: LAB) refocuses on core tools after SomaScan sale - Stock Titan
Standard BioTools Inc. $LAB Stake Boosted by Casdin Capital LLC - MarketBeat
Shorts Report: Can Standard BioTools Inc grow without dilution2026 Trading Recap & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Standard BioTools (NASDAQ:LAB) Cut to "Sell" at Wall Street Zen - MarketBeat
Retail Trends: Will Standard BioTools Inc stock hit new highs in YEARWeekly Market Report & Fast Momentum Entry Tips - baoquankhu1.vn
Does Standard BioTools Inc have declining or rising EPSJuly 2025 Chart Watch & Fast Momentum Entry Tips - baoquankhu1.vn
Aug PostEarnings: Should I invest in Standard BioTools Inc before earningsQuarterly Trade Summary & Expert Verified Movement Alerts - baoquankhu1.vn
LAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
LAB Technical Analysis & ETF Price Forecast - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Eli Casdin boosts equity stake in STANDARD BIOTOOLS (LAB) with 52,991 RSUs - Stock Titan
STANDARD BIOTOOLS (LAB) director takes 51,282 RSUs in lieu of $60K cash - Stock Titan
Retail Trends: Is Standard BioTools Inc a strong growth stockJuly 2025 Analyst Calls & Weekly High Return Opportunities - baoquankhu1.vn
Director at Standard BioTools (LAB) takes RSUs instead of cash pay - Stock Titan
Standard BioTools (NASDAQ:LAB) Upgraded to Hold at Wall Street Zen - marketbeat.com
Standard BioTools Inc. (LAB) Stock Analysis: Unveiling a 32% Upside Potential Amidst Challenging Metrics - DirectorsTalk Interviews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Globus Medical (GMED), Standard BioTools (LAB) and Addus Homecare (ADUS) - The Globe and Mail
Standard BioTools (LAB) Q4 Profit Challenges Longstanding Unprofitable Narrative - Sahm
Standard BioTools Q4 2025 Results: Profit on $23.8M RevenueNews and Statistics - IndexBox
Standard BioTools Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Standard BioTools (LAB) Reports Strong Q4 Revenue Exceeding Expe - GuruFocus
Standard BioTools Inc (NASDAQ:LAB) Surges on Strong Q4 Earnings Beat - ChartMill
Standard Biotools Inc (LAB) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.72%
大文字化:
|
ボリューム (24 時間):